Related Experiment Videos
Elevated Bcl-X(L) levels correlate with T cell survival in multiple sclerosis
Sonia Waiczies1, Alexandra Weber, Jan D Lünemann
1Division of Neuroimmunology, Department of Neurology, Neuroscience Research Center, Charité University Hospital, Building 2680, Schumannstr. 20/21, 10117 Berlin, Germany.
Journal of Neuroimmunology
|May 22, 2002
Summary
T cell resistance to activation-induced cell death (AICD) may drive multiple sclerosis (MS) pathogenesis. Increased Bcl-X(L) expression in MS patients
Area of Science:
- Immunology
- Neuroscience
Background:
- Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system.
- T cell resistance to activation-induced cell death (AICD) is implicated in MS pathogenesis.
- The Bcl-2 family of proteins regulates apoptosis.
Purpose of the Study:
- To investigate the expression of Bcl-2 family proteins in MS patients.
- To determine the role of Bcl-X(L) in T cell resistance to AICD in MS.
Main Methods:
- Protein expression analysis of Bcl-2, Bcl-X(L), and Bax in peripheral blood mononuclear cells (PBMC).
- In vitro model of AICD to assess T cell apoptosis susceptibility.
- Correlation analysis between Bcl-X(L) expression and AICD resistance.
Main Results:
- Increased Bcl-X(L) expression was observed in peripheral immune cells of MS patients.
- Bcl-X(L) expression directly correlated with resistance to AICD.
- No significant differences in Bcl-2 or Bax expression were found between MS patients and controls.
Conclusions:
- The anti-apoptotic factor Bcl-X(L) may contribute to T cell resistance in MS.
- Bcl-X(L) is a potential therapeutic target for MS.
- Understanding T cell apoptosis regulation is crucial for MS treatment.